Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Short-term Investments (2024 - 2025)

Plus Therapeutics (PSTV) has disclosed Short-term Investments for 2 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments rose 23.4% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, up 23.4% year-over-year, with the annual reading at $4.4 million for FY2025, 23.4% up from the prior year.
  • Short-term Investments for Q4 2025 was $4.4 million at Plus Therapeutics, up from $3.3 million in the prior quarter.
  • The five-year high for Short-term Investments was $4.6 million in Q2 2025, with the low at $323000.0 in Q1 2024.